The rise of neo: Neoadjuvant anti-PD1 in melanoma | 20 mins

(1 review)
743
students
1
Free

The availability of neoadjuvant immunotherapy is changing the way Stage III melanoma is managed. In this recorded presentation for our Melanoma Nurse In-Service Series,...

Free

Neoadjuvant immunotherapy: Revolutionising melanoma treatment | 36 min

(2 reviews)
2420
students
2
Free

Our latest podcast explores the innovative approach of neoadjuvant immunotherapy – administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach...

Free

The critical role of standardised pathological assessment in neoadjuvant therapy for melanoma: A guide for Pathologists | 40 min

(0 review)
2600
students
0
Free

The role of the Pathologist is crucial in the emerging field of neoadjuvant therapy in melanoma. Understanding that their role is fundamental to patient...

Free

Refining pathological response assessment in neoadjuvant therapy for melanoma | 40 min

(1 review)
2637
students
1
Free

In this presentation, Pathologist Prof Richard Scolyer AO discusses how neoadjuvant therapy is transforming melanoma patient care. He also answers key questions around neoadjuvant-treated...

Free

Neoadjuvant therapy in melanoma: The perfect model | 12 min

(0 review)
3288
students
0
Free

‘To shave or not to shave, that is the question.’ In this engaging debate, Dermatologist A/Prof Victoria Mar and Surgeon Prof Michael Henderson present...

Free

Neoadjuvant therapy in melanoma: Implications for primary care | 25 min

(0 review)
3478
students
0
Free

This presentation was recorded at the 2021 Australasian Skin Cancer Congress, organised by the Skin Cancer College Australasia. In this presentation, Medical Oncologist A/Prof...

Free

Neoadjuvant therapy in melanoma with Georgina Long | 45 min

(0 review)
3719
students
0
Free

In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Prof Hans Prenen on a recent publication in Nature Medicine...

Free